CERo Therapeutics
Price & Volume
Stats
See more52W Range | $0.003-$0.14 |
Shares Short | 0 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0 |
About
CEO | Mr. Christopher B. Ehrlich M.B.A. |
CFO | Mr. Andrew Albert Kucharchuk M.B.A. |
Address | 201 Haskins Way, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
